BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 32008974)

  • 1. Noninvasive Prenatal Testing for Trisomies 21, 18, and 13, Sex Chromosome Aneuploidies, and Microdeletions in Average-Risk Pregnancies: A Cost-Effectiveness Analysis.
    Xie X; Wang M; Goh ES; Ungar WJ; Little J; Carroll JC; Okun N; Huang T; Rousseau F; Dougan SD; Tu HA; Higgins C; Holubowich C; Sikich N; Dhalla IA; Ng V
    J Obstet Gynaecol Can; 2020 Jun; 42(6):740-749.e12. PubMed ID: 32008974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive Prenatal Testing for Trisomies 21, 18, and 13, Sex Chromosome Aneuploidies, and Microdeletions: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2019; 19(4):1-166. PubMed ID: 30847010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical performance of non-invasive prenatal served as a first-tier screening test for trisomy 21, 18, 13 and sex chromosome aneuploidy in a pilot city in China.
    Liu Y; Liu H; He Y; Xu W; Ma Q; He Y; Lei W; Chen G; He Z; Huang J; Liu J; Liu Y; Huang Q; Yu F
    Hum Genomics; 2020 Jun; 14(1):21. PubMed ID: 32503639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An assessment of the analytical performance of non-invasive prenatal testing (NIPT) in detecting sex chromosome aneuploidies: 34,717-patient sample in a single prenatal diagnosis Centre in China.
    Luo Y; Hu H; Zhang R; Ma Y; Pan Y; Long Y; Hu B; Yao H; Liang Z
    J Gene Med; 2021 Sep; 23(9):e3362. PubMed ID: 33973298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive prenatal testing for chromosome aneuploidies and subchromosomal microdeletions/microduplications in a cohort of 8141 single pregnancies.
    Hu H; Wang L; Wu J; Zhou P; Fu J; Sun J; Cai W; Liu H; Yang Y
    Hum Genomics; 2019 Mar; 13(1):14. PubMed ID: 30871627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical application and evaluation of health economics for non-invasive prenatal testing of fetuses in Tianjin].
    Ma R; Li X; Xu S; Shi Y; Ju D; Li Y; Meng F; Wang X; Du X; Xu N; Zhang Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2023 Feb; 40(2):135-142. PubMed ID: 36709929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive prenatal testing in routine clinical practice--an audit of NIPT and combined first-trimester screening in an unselected Australian population.
    McLennan A; Palma-Dias R; da Silva Costa F; Meagher S; Nisbet DL; Scott F
    Aust N Z J Obstet Gynaecol; 2016 Feb; 56(1):22-8. PubMed ID: 26817523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation of noninvasive prenatal testing for sex chromosome aneuploidies in 9,176 Korean pregnant women: a single-center retrospective study.
    Kim H; Park JE; Kang KM; Jang HY; Go M; Yang SH; Kim JC; Lim SY; Cha DH; Choi J; Shim SH
    BMC Pregnancy Childbirth; 2024 Jan; 24(1):93. PubMed ID: 38297236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive predictive value estimates for cell-free noninvasive prenatal screening from data of a large referral genetic diagnostic laboratory.
    Petersen AK; Cheung SW; Smith JL; Bi W; Ward PA; Peacock S; Braxton A; Van Den Veyver IB; Breman AM
    Am J Obstet Gynecol; 2017 Dec; 217(6):691.e1-691.e6. PubMed ID: 29032050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and Economic Impact of Adopting Noninvasive Prenatal Testing as a Primary Screening Method for Fetal Aneuploidies in the General Pregnancy Population.
    Kostenko E; Chantraine F; Vandeweyer K; Schmid M; Lefevre A; Hertz D; Zelle L; Bartha JL; Di Renzo GC
    Fetal Diagn Ther; 2019; 45(6):413-423. PubMed ID: 30130800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-Free DNA-Based Non-invasive Prenatal Screening for Common Aneuploidies in a Canadian Province: A Cost-Effectiveness Analysis.
    Nshimyumukiza L; Beaumont JA; Duplantie J; Langlois S; Little J; Audibert F; McCabe C; Gekas J; Giguère Y; Gagné C; Reinharz D; Rousseau F
    J Obstet Gynaecol Can; 2018 Jan; 40(1):48-60. PubMed ID: 28784564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential impact of NIPT as a second-tier screen on the outcomes of high-risk pregnancies with rare chromosomal abnormalities.
    Maxwell S; Dickinson JE; Murch A; O'Leary P
    Aust N Z J Obstet Gynaecol; 2015 Oct; 55(5):420-6. PubMed ID: 26286670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The consequences of implementing non-invasive prenatal testing in Dutch national health care: a cost-effectiveness analysis.
    Beulen L; Grutters JP; Faas BH; Feenstra I; van Vugt JM; Bekker MN
    Eur J Obstet Gynecol Reprod Biol; 2014 Nov; 182():53-61. PubMed ID: 25238658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancy outcome of autosomal aneuploidies other than common trisomies detected by noninvasive prenatal testing in routine clinical practice.
    Wan J; Li R; Zhang Y; Jing X; Yu Q; Li F; Li Y; Zhang L; Yi C; Li J; Li D; Liao C
    Prenat Diagn; 2018 Oct; 38(11):849-857. PubMed ID: 30078205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive prenatal testing for chromosome aneuploidies and subchromosomal microdeletions/microduplications in a cohort of 42,910 single pregnancies with different clinical features.
    Chen Y; Yu Q; Mao X; Lei W; He M; Lu W
    Hum Genomics; 2019 Nov; 13(1):60. PubMed ID: 31783780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal screening for fetal aneuploidies with cell-free DNA in the general pregnancy population: a cost-effectiveness analysis.
    Fairbrother G; Burigo J; Sharon T; Song K
    J Matern Fetal Neonatal Med; 2016; 29(7):1160-4. PubMed ID: 26000626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanded noninvasive prenatal testing for fetal aneuploidy and copy number variations and parental willingness for invasive diagnosis in a cohort of 18,516 cases.
    Ge Y; Li J; Zhuang J; Zhang J; Huang Y; Tan M; Li W; Chen J; Zhou Y
    BMC Med Genomics; 2021 Apr; 14(1):106. PubMed ID: 33853619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical application of expanded noninvasive prenatal testing for fetal chromosome abnormalities in a cohort of 39,580 pregnancies.
    Chen Y; Lu L; Zhang Y; Wang F; Ni Y; Wang Q; Ying C
    Am J Med Genet A; 2022 May; 188(5):1426-1434. PubMed ID: 35107205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of prenatal screening and diagnostic strategies for Down syndrome: A microsimulation modeling analysis.
    Zhang W; Mohammadi T; Sou J; Anis AH
    PLoS One; 2019; 14(12):e0225281. PubMed ID: 31800591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical utility of non-invasive prenatal testing in pregnancies with ultrasound anomalies.
    Beulen L; Faas BHW; Feenstra I; van Vugt JMG; Bekker MN
    Ultrasound Obstet Gynecol; 2017 Jun; 49(6):721-728. PubMed ID: 27515011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.